华法林为临床上最常用的抗凝药物。
目的探讨华法林溶解左心耳血栓的机制。
Objective To study the mechanism of left atrial appendage thrombi resolution after anticoagulation with warfarin.
如果那不是华法林呢？
这类药物的例子包括尤其是曲马朵和华法林。
Examples of such drugs include, in particular, tramadol and warfarin.
谨慎使用与个人服用华法林或其他血液稀释药物。
Use caution with individuals taking warfarin or other blood thinning medications.
目的研究心脏机械瓣膜置换术后华法林钠的应用。
Objective To investigate the use of warfarin sodium after mechanical heart valve replacement.
用于生产双香豆素、新抗凝，华法林等抗凝血药物。
For the production of double-coumarin, a new anticoagulant, warfarin, and other anti-clotting drugs.
双香豆素因吸收不规则、不完全，已被华法林等所取代。
Dicoumarin due to absorption of irregular, incomplete, has been replaced by warfarin.
包括我的很多医生都会建议你使用一种抗凝药，比如华法林。
Many doctors, including me, would advise you to take an anticoagulant such as warfarin indefinitely.
的影响，低剂量华法林对中风的风险，在患者与非风湿性房颤。
The effect of low-dose warfarin on the risk of stroke in patients with nonrheumatic atrial fibrillation.
对机械瓣替换的儿童常规应用华法林抗凝能取得良好的远期效果。
Routine use of warfarin for anticoagulation in mechanical valve replacement children has proved safe and feasible in the long run.
目的观察噻氯吡啶与华法林在治疗心腔内附壁血栓的疗效及安全性。
Objective To investigate the safety and efficiency of ticlopidine and warfarin on intracardiac mural thrombus.
目的探讨心瓣膜置换术后血浆华法林浓度的动态变化及其临床意义。
Objective To study variation of plasma warfarin concentration and its clinical significance in patients with heart valve replacement.
华法林和阿司匹林不应该采取在同一时间，因为是一项高风险的出血。
Warfarin and aspirin should not be taken at the same time because there is a high risk of bleeding.
当怀疑华法林治疗引起坏死时，则须停止治疗，并且考虑使用肝素。
Warfarin therapy should be discontinued when Warfarin is suspected to be the cause of developing necrosis and heparin therapy may be considered for anticoagulation.
为了减少华法林过弱或过强抗凝治疗的危险，这些差异必须给予考虑。
These differences must be taken into account when administering warfarin in order to minimize the risk of under- or over-anticoagulation.
当怀疑华法林治疗引起坏死时，则须停止治疗，并且考虑使用肝素治疗。
Warfarin therapy should be discontinued when warfarin is suspected to be the cause of developing necrosis and heparin therapy may be considered for anticoagulation.
患者于2009年5月12号出院，接受华法林(2.5mg每日)的维持治疗。
She was discharged home on May 12, 2009, and accepted warfarin (2 · 5 mg per day) as maintenance therapy.
方法：回顾性分析符合纳入标准的214例服用华法林患者的相关临床资料。
METHODS: a retrospective analysis of related clinical data of 214 patients who meet the inclusion criteria was performed.
血液稀释剂抗凝剂可以降低产生血凝块的危险。包括肝素、华法林(香豆素)。
Blood thinners. Medications called anticoagulants help decrease your blood's ability to clot and reduce your risk of developing blood clots. Anticoagulants include heparin or warfarin (Coumadin).
已知华法林可以和一定范围的药物甚至是一些食物与饮料互相作用，例如酸莓汁。
Warfarin is known to interact with a range of drugs and even some foods and drinks, such as cranberry juice.
组给予中药煎汤另服华法林钠，使血浆凝血酶原时间保持在正常的1 5倍左右；
Group A was given herbal medicine soup together with Warfarin Sodium Tablets, keeping plasma thrombinogen time at 1.5 times as normal.
目的：探讨维生素k_1对运用华法林患者起搏器植入术后囊袋血肿发生的影响。
ObjectiveTo study the effect of Vitamin K1 on the occurrence of Pocket hematoma after the implantation of pacemaker in the patients who take Warfarin.
华法林已经证明了它是一个有效的预防血栓栓塞的药物，但是，它也并不是没有缺点。
Warfarin has demonstrated efficacy as an effective chemoprophylaxis agent against thromboembolic disease; however, it is not without its disadvantages.
克罗斯比两边的第一根肋骨都被摘除，很快他就停止服用华法林阻凝剂，他已经四年没有在发病了。
Crosby had his first rib removed from each side and was soon able to stop taking the warfarin. He has been symptom-free for four years.
这位新西兰女子服用华法林-一种阻凝剂进行治疗，它会使血块在一周之内几乎全部消失。
The New Zealand woman was treated with warfarin, an anti-coagulant, which resulted in the clot disappearing almost entirely within a week.
结论：部分服用华法林患者抗凝治疗质量较差，需加强抗凝治疗质量的管理，使抗凝安全、有效。
CONCLUSIONS: the anticoagulant therapy in some patients who took warfarin shows poor quality, it needs strengthening the quality management to make it safe and effective.
摘要：目的：评价服用华法林患者的抗凝治疗质量，为加强服用华法林患者的管理提供数据支持。
ABSTRACT: OBJECTIVE: to evaluate the quality of anticoagulant therapy in patients who took warfarin and provide data supporting for strengthening the management of these patients.
摘要：目的：评价服用华法林患者的抗凝治疗质量，为加强服用华法林患者的管理提供数据支持。
ABSTRACT: OBJECTIVE: to evaluate the quality of anticoagulant therapy in patients who took warfarin and provide data supporting for strengthening the management of these patients.
应用推荐